Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
US7572795B2 · kind B2 · utility
2Cited by
11References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2007 |
| Grant date | Aug 11, 2009 |
| Priority date | — |
| Expiry date | Mar 6, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having the Formula (I), including pharmaceutically acceptable salts thereof,wherein at least one of X1, X2 or X3 isand any remaining X1, X2 or X3 is hydrogen, which are useful as kinase inhibitors, wherein R1, R2, R3, R4, R5, R6, A1, A2 and m are as described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.